Condition: Breast Cancer · Hair Loss · Sponsor: GenieBiome Limited
This study aims to explore the efficacy and safety of a synbiotic formula (BLHK03) in alleviating chemotherapy-induced alopecia (CIA) in breast cancer patients and the compositional and functional changes in the gut microbiome of breast cancer patients undergoing chemotherapy and treatment with BLHK03.
This description comes directly from the study's public registry record.
Emily Chiu, BSc · 97405209 · emilychiu@g-niib.com
Pui Kuan Cheong, MPH · 97405209 · jcheong@g-niib.com
Always discuss trial participation with your own doctor first.
| GenieBiome Limited | Hong Kong, Hong Kong | Not Yet Recruiting |
| Heal Medical | Hong Kong, Hong Kong | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06560385